索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]李益萍,王肖龙.氧化低密度脂蛋白对泡沫细胞形成的作用[J].国际心血管病杂志,2015,05:335-337.
点击复制

氧化低密度脂蛋白对泡沫细胞形成的作用(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2015年05期
页码:
335-337
栏目:
综述
出版日期:
2015-09-25

文章信息/Info

Title:
-
作者:
李益萍; 王肖龙
200021 上海中医药大学附属曙光医院心血管科,上海市中医临床重点实验室(14DZ2273200)
Author(s):
-
关键词:
氧化低密度脂蛋白; 泡沫细胞; 结合受体; 信号转导通路
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2015.05.012
文献标识码:
-
摘要:
氧化低密度脂蛋白(ox-LDL)与巨噬细胞间的相互作用是泡沫细胞形成的重要机制,在动脉粥样硬化发生、发展中起重要作用。该文介绍ox-LDL的主要结合受体、ox-LDL刺激泡沫细胞形成的相关信号通路。
Abstract:
-

参考文献/References

[1] Ross R.Atherosclerosis—an inflammatory disease[J].N Engl J Med,1999,340(2): 115-126.
[2] Steinberg D.Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime[J].Nat Med,2002,8(11): 1211-1217.
[3] Vendrov AE,Hakim ZS, Madamanchi NR,et al.Atherosclerosis is attenuated by limiting superoxide generation in both macrophages and vessel wall cells[J].Arterioscler Thromb Vasc Biol,2007,27(12):2714-2721.
[4] 徐瑞霞,李建军. 氧化型低密度脂蛋白胆固醇与动脉粥样硬化[J].中国医学前志(电子版),2012,4(8):33-37.
[5] 熊 涛,吴兴军,王逸平. 丹参多酚酸盐抑制低密度脂蛋白氧化修饰[J].中药药理与临床,2004,20(4):7-8.
[6] 包 良,白海鹏, 萨朝夫等.蒙古多糖抗氧化活性及其对血管的保护作用[J]. 内蒙古大学学报(自然科学版),2014,45(5):498-502.
[7] Platt N, Haworth R, Darley L,et al. The many roles of the class A macrophage scavenger receptor[J].Int Rev Cytol, 2002,212:1-40.
[8] Febbraio M,Hajjar DP.Silverstein RL. CD36:A class B scavenger receptor involved in angiogenesis,atherosclerosis,inflammation,and lipid metabolism[J].Clin Invest,2001,108(6):785-791.
[9] Suzuki H, Kurihara Y, Takeya M, et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection[J].Nature, 1997,386(6622):292-296.
[10] Febbraio M, Podrez EA, Smith JD, et al. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice[J].Clin Invest, 2000,105(8):1049-1056.
[11] Akhmedov A, Rozenberg I, Paneni F, et al. Endothelial overexpression of LOX-1 increases plaque formation and promotes atherosclerosis in vivo[J]. Eur Heart J, 2014,35(40):2839-2848.
[12] de Villiers WJ, Smart EJ.Macrophage scavenger receptors and foam cell formation[J].J Leukoc Biol, 1999,66(5):740-746.
[13] Mäkinen PI,Lappalainen JP,Heinonen SE,et al.Silencing of either SR-A or CD36 reduces atherosclerosis inhyperlipidemic mice and reveals reciprocal upregulation of the sereceptors[J].Cardiovasc Res, 2010, 88(3):530-538.
[14] Manning-Tobin JJ, Moore KJ, Seimon TA,et al. Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice[J]. Arterioscler Thromb Vasc Biol,2009,29(1):19-26.
[15] Szilagyi K, Meijer AB, Neele AE,et al. PKCδ is dispensible for oxLDL uptake and foam cell formation by human and murine macrophages[J]. Cardiovasc Res, 2014,104(3):467-476.
[16] Zhang Q, Sha Ma AZ, Wang C, et al. Nifedipine inhibits ox-LDL-induced lipid accumulation in human blood-derived macrophages[J]. Biochem Biophys Res Commun, 2015,457(3):440-444.
[17] Rios FJ,Ferracini M,Pecenin M,et al.Uptake of oxLDL and IL-10 production by macrophages requires PAFR and CD36 recruitment into the same lipid rafts[J].PLoS One,2013,8(10): e76893.
[18] Liu W,Yin Y,Zhou Z,et al. Ox-LDL-induced IL-1beta secretion promoting foam cells formation was mainly via CD36 mediated ROS production leading to NLRP3 inflammasome activation[J]. InflammRes,2014,63(1): 33-43.
[19] Li X, Zhou Y, Yu C,et al.Paeonol suppresses lipid accumulation in macrophages via upregulation of the ATP binding cassette transporter A1 and downregulation of the cluster of differentiation 36[J].Int J Oncol,2015,46(2):764-774.
[20] 王慧婷,朱 毅. 血凝素样氧化低密度脂蛋白受体-1[J].国际心血管病杂志,2009,36(4):225-227.
[21] Navarra T,Del Turco S,Beiti S,et al.The Lection-like oxidized low density lipo-protein receptor-1 and its soluble foam:cardiovusular implication [J].J Atherosler Thromb,2010,17(4):317-331.
[22] Panicker SR, Kartha CC.Curcumin attenuates glucose-induced monocyte chemoatt ractant protein-1 synthesis in aortic endothelial cells by modulating the nuclear factor-kappaB pathway [J].Pharmacology,2010,85(1): 18-26.
[23] Akamatsu T, Dai H, MizuguchiM,et al. LOX-1 is a novel therapeutic target in neonatal hypoxic-ischemic encephalopathy[J]. Am J Pathol,2014,184(6):1843-1852.
[24] 朱中生,王海燕,王登峰,等.瑞舒伐他汀对载脂蛋白E基因缺陷小鼠动脉粥样硬化及LOX-1、NF-κB p65表达的影响[J].解放军医学杂志,2014,39(12):946-949.
[25] Hao Q, Chen X, Zhou X,et al.Bu-shen-he-mai-fang(HMF)decoction inhibits atherosclerosis by improving antioxidant and anti-inflammatory activities in ApoE-deficient mice[J].Int J Biomed Sci,2014,10(4):258-264.
[26] Zhang H,Ma G,Yao Y,et al.Olmesartan attenuates the impairment of endothelial cells induced by oxidlized low density lipoprotein through down regulating expression of Lox-1[J].Int J Mol Sci,2012,13(2):1512-1523.
[27] Chen CY, Yi L, Jin X, Zhang T,et al.Inhibitory effect of delphinidin on monocyte-endothelial cell adhesion induced by oxidized low-density lipoprotein via ROS/p38MAPK/NF-κB pathway[J]. Cell Biochem Biophys,2011,61(2):337-348.
[28] Bao MH, Zhang YW, Zhou HH.Paeonol suppresses oxidized low-density lipoprotein induced endothelial cell apoptosis via activation of LOX-1/p38MAPK/NF-κB pathway[J]. J Ethnopharmacol,2013,146(2):543-551.
[29] 杨永宗,阮长耿.动脉粥样硬化性心血管病基础与临床(第二版)[M].北京:科学出版社,2009:644-645.
[30] Chinetti-Gbaguidi G, Baron M, Bouhlel M A, et al. Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPARγ and LXRα pathways[J].Circ Res, 2011, 108(8):985-995.
[31] Lin XL, He XL, Zeng JF,et al. FGF21 increases cholesterol efflux by upregulating ABCA1 through the ERK1/2-PPARγ-LXRα pathway in THP1 macrophage-derived foam cells[J].DNA Cell Biol,2014,33(8):514-521.
[32] Ma X, Li SF, Qin ZS,et al. Propofol up-regulates expression of ABCA1, ABCG1, and SR-BⅠ through the PPARγ/LXRα signaling pathway in THP-1 macrophage-derived foam cells[J].Cardiovasc Pathol,2015,24(4):230-235.

备注/Memo

备注/Memo:
基金项目:上海市自然科学基金(12ZR1432600),上海市科技创新行动计划(12401903400、14401972202) 作者单位:200021 上海中医药大学附属曙光医院心血管科,上海市中医临床重点实验室(14DZ2273200) 通信作者:王肖龙,Email:wxlqy0214@163.com
更新日期/Last Update: 2015-10-20